logo

Celldex Therapeutics Inc. (CLDX)



Trade CLDX now with
  Date
  Headline
1/4/2021 8:22:39 AM Celldex Appoints Freddy Jimenez SVP And General Counsel
10/13/2020 8:16:51 AM Celldex Says First Patient Dosed In Randomized, Double-blind Phase 1b Study Of CDX-0159
5/6/2020 8:07:07 AM Celldex Says Results From Phase 1 Study Of CDX-0159 Accepted As Late-breaking Poster Presentation At EAACI
11/18/2019 8:16:55 AM Celldex Says Phase 1a Study Of CDX-0159 Has Initiated In Healthy Volunteers
6/24/2019 8:06:25 AM Celldex Therapeutics Appoints Diane Young SVP, Chief Medical Officer
2/8/2019 12:21:42 PM Celldex Therapeutics Announces 1 For 15 Reverse Stock Split
11/9/2018 8:02:47 AM Celldex Presents Promising Interim Data From Phase 1 Study Of Differentiated CD40 Agonist CDX-1140
11/7/2018 4:11:03 PM Celldex Therapeutics Q3 Loss/share $0.04 Vs. Loss $0.20 Year Ago
8/8/2018 4:03:58 PM Celldex Therapeutics Q2 Loss/share $0.11 Vs. Loss $0.23 Year Ago